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Introduction
The treatment of patients with aortic regurgitation (AR) or
mitral regurgitation (MR) relies on the accurate assess-
ment of the severity of the regurgitation and its effect on
left ventricular (LV) size and function. CMR is an excellent
tool for quantifying regurgitant volumes and LV size and
function. The 2006 AHA/ACC management guidelines for
the therapy of patients with AR or MR describe LV size in
terms of linear dimensions (i.e. end-diastolic and end-
systolic dimension). LV volumes that correspond to these
linear dimensions have not been published in the peer-
reviewed literature.
Purpose
To determine the effect of regurgitant volume on LV vol-
umes and chamber dimensions in patients with isolated
AR or MR and preserved LV function.
Methods
This study comprises 62 consecutive CMR exams in 57
patients with isolated AR or MR. LV volumes were deter-
mined from short and long-axis 1.5 T FIESTA images using
a semiautomated algorithm (ReportCard 4.0). Flow in the
proximal aorta and pulmonary artery was assessed with
phase-contrast imaging. Baseline correction was per-
formed using a stationary phantom. AR volume was deter-
mined by integrating aortic blood flow throughout
diastole. MR volume was determined as the difference
between LV stroke volume and pulmonary artery flow. To
determine the reproducibility of AR and MR regurgitant
volume, a second blinded analysis was made according to
the same method.
Results
There is a strong, linear relationship between regurgitant
volume and LV end-diastolic volume index (AR r2 = 0.8,
MR r2 = 0.8) (figure). Bland Altman analysis of regurgitant
volume shows little interobserver variation (AR: 0.6 + 4
ml; MR: 4 + 6 ml). The correlation is much poorer
between regurgitant volume and commonly used clinical
linear measures such as end-systolic dimension (MR r2 =
0.2, AR r2 = 0.5). Linear regression is used to determine the
LV volumes that correspond to the linear dimensions cur-
rently recommended in the 2006 AHA/ACC management
guidelines (Figure 1, Table 1).
Conclusion
MRI is a robust technique for quantification of regurgitant
volume in patients with AR or MR and preserved LV func-
tion. Ventricular volumes show a stronger correlation
with regurgitant volume than linear dimensions, suggest-
ing LV volumes better reflect ventricular remodeling in
patients with isolated mitral or aortic regurgitation. For a
given regurgitant volume, AR results in greater LV enlarge-
ment than patients with MR, likely due to the fact that MR
is a pure volume lesion whereas AR is both a pressure and
a volume lesion. Ventricular volumes that correspond to
published recommended linear dimensions are deter-
mined to guide the timing of surgical intervention.
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